Generics 13

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Cyclobenzaprine hydrochloride manufacturers

13 products found

Filters

13 products found

cyclobenzaprine hydrochloride

Tablets 5 mg, 10 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #18865

Manufacturer usually replies in 4 days

cyclobenzaprine hydrochloride

Tablets 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Canada
GMP approvals
Canada
Manufacturer #17782
Over 40 years ago, it was founded in North America. The company has long been a leader in the generic product manufacturing industry. It has earned a name for itself in the production of branded and over-the-counter private label items. Customers are actively and attentively listened to by the company. They anticipate the evolution of new markets and are ready to adapt to new medical needs.

Manufacturer usually replies in 8 days

cyclobenzaprine hydrochloride

Tablets 5 mg, 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
FDA
Manufacturer #20861

Manufacturer usually replies in 4 days

cyclobenzaprine hydrochloride

Tablets 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
Sri Lanka, Afghanistan, Vietnam, Cambodia, Myanmar
Manufacturer #21102

Manufacturer usually replies in 5 days

cyclobenzaprine hydrochloride

Capsules 15 mg, 30 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
Sri Lanka, Afghanistan, Vietnam, Cambodia, Myanmar
Manufacturer #21102

Manufacturer usually replies in 5 days

cyclobenzaprine hydrochloride

Tablets 5 mg, 7.5 mg, 10 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, PICS
Unavailable markets
South Africa
Manufacturer #638

Manufacturer usually replies in 8 days

cyclobenzaprine hydrochloride

Tablets, modified release (MR) 10 mg, 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Chile
GMP approvals
WHO, INVIMA
Manufacturer #18571
The company produces and markets ophthalmologic products exclusively but expanded rapidly to other specialties, trying to obtain the position of one of the leaders within the international pharmaceutical industry. The company aspires to have the values of respect, loyalty, integrity, and responsibility, amongst others, prevail in all of its relationships with workers, authorities, competitors, clients, and the community at large.

Manufacturer usually replies in 5 days

cyclobenzaprine hydrochloride

Tablets 10 mg, 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Palestinian Territory
GMP approvals
Jordan
Manufacturer #20728

cyclobenzaprine hydrochloride

Tablets, film coated 5mg, 10mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #19063
It is a pharmaceutical company. It provides bullets, cosmetics and health products, medicines, food supplements, and more.

Manufacturer usually replies in nan days

cyclobenzaprine hydrochloride

Tablets 5 mg, 7.5 mg, 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, WHO
Manufacturer #675

lysine + cyclobenzaprine hydrochloride

Tablets, film coated 125 mg + 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17925
The company’s goal is to exceed its accomplishments to improve the quality of living, as well as the hope and well-being of millions of people. The company’s dedication to quality has allowed it to achieve prestige and significant market share. The core focus of the company is the development, production, and marketing of pharmaceutical products designed to help healthcare providers improve healthcare delivery.

Manufacturer usually replies in 7 days

aceclofenac + cyclobenzaprine hydrochloride

Tablets 200 mg+15 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19051

Manufacturer usually replies in 14 days

piroxicam + lidocaine + cyclobenzaprine hydrochloride

Cutaneous gel 5 mg/g + 20 mg/g + 5 mg/g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #15086
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products for 20+ years. Key production lines are Rx, OTC, medical devices, nutraceuticals, and cosmetics. The company's production lines are GMP-compliant. ain therapeutic areas include respiratory, dermatology, and urinary. The main dosage forms include solid oral, liquid, and semi-solid.

Manufacturer usually replies in 19 days

CYCLOBENZAPRINE HYDROCHLORIDE Manufacturer

Cyclobenzaprine is a medical substance that is used short-term to cure muscle spasms. It is normally used along with rest and physical cure. It works to relax the muscles. Warnings: Follow all Instructions on your medicine package and label. It is wise to tell your healthcare providers about all your medical allergies, illnesses, and all medicines you use. Before taking Cyclobenzaprine: You should not use This medical remedy if you are allergic to it This drug may also be used for purposes that may not have been listed in this medication guide.

How does CYCLOBENZAPRINE HYDROCHLORIDE work?

This medicine should be taken by mouth with or without food as instructed by your doctor, regularly once. Consume the mixtures and then drink water to make sure you have swallowed all of the medication. You should not prepare the mixture before time for later use, it may destroy the drugs.

How much money does CYCLOBENZAPRINE HYDROCHLORIDE cost?

It is obtainable in generic and brand versions. It is not covered by most Medicare and insurance plans, but pharmacy coupons can help balance the price. The cost for CYCLOBENZAPRINE HYDROCHLORIDE 100 per unit is $1.95. Prices may vary depending on the pharmacy you visit.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of CYCLOBENZAPRINE HYDROCHLORIDE offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for CYCLOBENZAPRINE HYDROCHLORIDE manufacturers and CYCLOBENZAPRINE HYDROCHLORIDE suppliers that you are looking for. These also enable you to check the dossier status, and the GMP approvals of the different variants. Also, each manufacturer or supplier product description contains essential information about CYCLOBENZAPRINE HYDROCHLORIDE including clinical data, stability zones, countries where CYCLOBENZAPRINE HYDROCHLORIDE is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over Ivermectin offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that Ivermectin manufacturers have, we qualify their companies before they are on boarded on the platform. This allows us to screen Ivermectin manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.